Correlation Between Sumitomo Dainippon and Procyon
Can any of the company-specific risk be diversified away by investing in both Sumitomo Dainippon and Procyon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Dainippon and Procyon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Dainippon Pharma and Procyon, you can compare the effects of market volatilities on Sumitomo Dainippon and Procyon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Dainippon with a short position of Procyon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Dainippon and Procyon.
Diversification Opportunities for Sumitomo Dainippon and Procyon
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sumitomo and Procyon is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Dainippon Pharma and Procyon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procyon and Sumitomo Dainippon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Dainippon Pharma are associated (or correlated) with Procyon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procyon has no effect on the direction of Sumitomo Dainippon i.e., Sumitomo Dainippon and Procyon go up and down completely randomly.
Pair Corralation between Sumitomo Dainippon and Procyon
If you would invest 19.00 in Procyon on September 1, 2024 and sell it today you would earn a total of 1.00 from holding Procyon or generate 5.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Sumitomo Dainippon Pharma vs. Procyon
Performance |
| Timeline |
| Sumitomo Dainippon Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Procyon |
Sumitomo Dainippon and Procyon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sumitomo Dainippon and Procyon
The main advantage of trading using opposite Sumitomo Dainippon and Procyon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Dainippon position performs unexpectedly, Procyon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procyon will offset losses from the drop in Procyon's long position.| Sumitomo Dainippon vs. Hypera SA | Sumitomo Dainippon vs. YourWay Cannabis Brands | Sumitomo Dainippon vs. Cumberland Pharmaceuticals | Sumitomo Dainippon vs. Genomma Lab Internacional |
| Procyon vs. Hypera SA | Procyon vs. YourWay Cannabis Brands | Procyon vs. Cumberland Pharmaceuticals | Procyon vs. Genomma Lab Internacional |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |